...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Additional Exempt Distributions
2
Sep 17, 2023 04:45PM

koo wrote - "More than not, all the Promissory Notes were made by Don M."

Koo, does this mean that Don is pouring millions into ZCC??? Note sure I understand what your statement means.

Thanks.

Toinv

Share
New Message
Please login to post a reply